The government alleged that Golden Meadows Hospice and D’Alexandria Hospice billed Medicare more than $4.8 million in a scheme involving marketer kickbacks and patients who were not terminally ill. Its account also put a marketer inside the pressure on a nurse practitioner’s assessments: patients found ineligible became terminally ill on paper. The alleged arrangement connected what marketing wanted with what the clinical record said and how long Medicare kept paying.
According to the Justice Department, Golden Meadows Hospice Inc. and D’Alexandria Hospice Inc. operated under the same owner in West Covina, California. Its June 3, 2025 account described an alleged hospice fraud scheme running from September 2018 through October 2022. The government said the hospices billed Medicare for people who were not terminally ill.
The government alleged referral payments of up to $1,300 per patient for every month the patient stayed on hospice service. The government said the owner worked with another participant to pay marketers to recruit patients, knowing that most had not been referred for hospice by their primary care physicians. According to the government, the kickbacks were often called “girl scout cookies” internally.
A recurring payment gives the recruiter a financial interest in the length of the stay. The hospice gets paid for enrolled days, and the marketer’s alleged payment follows the same patient’s continued enrollment. Getting someone through intake starts a relationship that can keep paying both sides.
That arrangement fits the economics of hospice payment. Medicare pays a daily rate even on days when nobody visits. In its January 2015 report, Medicare Hospices Have Financial Incentives to Provide Care in Assisted Living Facilities, the Office of Inspector General explained the incentive plainly:
Therefore, a hospice stands to gain financially if it provides minimal services to a beneficiary over a long period of time.
Medicare Hospices Have Financial Incentives to Provide Care in Assisted Living Facilities, HHS Office of Inspector General, 2015
In the Golden Meadows allegations, the monthly referral payment put that interest in continued enrollment into the marketer’s compensation too.
Hospice fraud can connect paid recruitment, falsified assessments and Medicare billing. In the Golden Meadows account, the government alleged that marketers and the owner pressured a clinician to make ineligible patients appear terminally ill. The marketer’s alleged influence reached the clinical account of whether the patient belonged in hospice.
The government said the nurse practitioner conducting initial assessments found many patients ineligible. It alleged that the owner and marketers, including the marketer at the center of this account, pressured the practitioner, who exaggerated and falsified patients’ conditions to make them appear terminally ill. According to that account, the owner made the ultimate enrollment decisions despite not being a medical professional, and hospice physicians relied on the practitioner’s records to certify patients as appropriate for hospice.
That sequence puts the marketer’s role upstream of the signature. The physician received an assessment that the government said had already been changed under commercial pressure. For an insider who saw the patient or the original assessment, the difference between the patient’s condition and the account sent for certification is central to hospice eligibility fraud.
Medicare hospice eligibility requires certification of a life expectancy of six months or less if the illness runs its normal course. The government alleged that the enrolled patients rarely died and were often discharged around six months at the owner’s direction, sometimes into her home health company or the other hospice. In that account, management controlled both the decision to enroll and the later move out of the hospice. Medicare was paying for care meant for the dying while the business recruited people who were not terminally ill.
Medicare paid more than $3.8 million on the alleged false claims, according to the Justice Department. The payments went to the hospices whose enrollment the marketers helped supply.
The monthly marketer fee sat earlier in the business: paying for the patient whose enrollment generated the claim. For a hospice billing fraud case, we connect that referral arrangement to the enrollment and the bills for the same patient.
A hospice referral-payment arrangement can be the subject of a civil health care fraud case under the False Claims Act. Tapestry Hospice agreed to a $1.4 million healthcare kickback settlement in 2024 after the Justice Department alleged that medical directors’ compensation rose and fell with referrals. The alleged payments included monthly stipends and a signing bonus.
The connection is the way compensation follows the patient flow. Tapestry’s alleged arrangement paid medical directors. The Golden Meadows account describes payments to marketers that continued with enrollment. Both accounts give an insider a concrete relationship to explain: who controlled referrals and what the hospice paid for them.
Other hospice complaints describe staffing and services used to secure referrals. In the AseraCare whistleblowers’ complaint, the allegation was that a nursing facility with several AseraCare hospice patients could receive a full-time employee. The whistleblowers described that staffing as a subsidy in exchange for a ready source of referrals.
The Care Alternatives whistleblowers’ complaint described the instructions to marketing staff this way:
Marketers/community liaisons were told to do what ever was necessary to “bring in the bodies”.
Whistleblowers’ allegation, United States of America and State of New Jersey ex rel. Victoria Druding; Barbara Bain; Linda Coleman; Ronni O’Brien v. Care Alternatives, first amended complaint, paragraph 34
The same complaint alleged promises of extra aides and full-time nurses, along with meals, bonuses and gifts. It also alleged that scheduled education programs for facility staff would be canceled if the facility did not refer enough patients. Even an education program allegedly had a patient target attached.
These allegations show why the arrangement’s terms matter. A monthly fee, a promised employee and a canceled program leave different records. The common question is what benefit depended on the referral. That is the comparison with Golden Meadows, where the alleged payment formula explicitly followed each month of hospice service.
To identify hospice fraud involving monthly referral payments, we connect the referral source, the payment arrangement, the patient’s enrollment and the Medicare claims. Where clinical pressure is involved, we also examine what the clinician first recorded, what changed and who wanted the change.
An intake worker may know who brought the patient in. A marketer may know the payment formula. A clinician may have seen an assessment challenged by someone whose compensation depended on admission. A biller may see the claim periods and the provider receiving payment. Those views can explain how a paid referral became a paid claim.
The useful account is specific to the work you saw: a monthly payment tied to a patient, an instruction to change an assessment, or a discharge directed by the same management that controlled admission. Our whistleblower experts work with you to connect those decisions and the records behind them.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
If you know who was paid for hospice patients or who pushed an assessment toward admission, talk with our whistleblower experts about the arrangement you saw. We build the case with you and bring in hospice fraud whistleblower lawyers who understand referral payments and clinical certification. We stay beside you as the patient, payment and management decisions become your whistleblower case.